Novo Nordisk A/S vs Stanley Black & Decker, Inc. — how do they compare? Novo Nordisk A/S trades at $49.35 (market cap $220.53B), while Stanley Black & Decker, Inc. trades at $87.62 (market cap $13.60B). The key difference: Novo Nordisk A/S is far larger — about 16.2× Stanley Black & Decker, Inc.'s market cap, and Stanley Black & Decker, Inc. pays the higher dividend (3.79%). Which is the better fit depends on your goals.
| NVO | SWK | |
|---|---|---|
Market Cap | $220.53B | $13.60B |
Sector | Health | — |
52-Week High | $71.70 | $94.12 |
52-Week Low | $35.29 | $62.12 |
Enterprise Value | $239.49B | $19.77B |
Dividend Yield | 3.63% | 3.79% |
Trailing returns across standard periods
Latest headlines on both assets
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →Stanley Black & Decker Inc is a manufacturer of hand and power tools. The company operates three business segments: tools and storage, security, and industrial. Tools and storage, the largest segment by revenue, sells hand tools and power tools to professional end-users, distributors, retail consumers, and industrial customers. Security installs electronic security systems and provides electronic security services including alarm monitoring and video surveillance. Industrial sells engineered fastening products such as stud-welding systems, blind inserts and tools, and engineered plastic and mechanical fasteners. The largest end market is the United States of America.
Read more on SWK →